Radiating Positivity: Roche’s Actemra Sees More Positive Results In Third Pivotal Trial

After announcing positive results from its RADIATE study, Roche awaits monotherapy study results to determine whether to file as first-line treatment, firm tells “The Pink Sheet” DAILY.